Literature DB >> 15905579

Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection.

Farshid Noorbakhsh1, Nathalie Vergnolle, Justin C McArthur, Claudia Silva, Mohammed Vodjgani, Patricia Andrade-Gordon, Morley D Hollenberg, Christopher Power.   

Abstract

Proteinase-activated receptors (PARs), a newly discovered subgroup of G-protein coupled receptors, are widely expressed by neural cells, but their roles in the nervous system remain uncertain. In this study, we report that PAR-2 was up-regulated on neurons in conjunction with neuroinflammation in brain tissue from patients with HIV-1-associated dementia. The inflammatory cytokines TNF-alpha and IL-1beta were also increased in HIV-1-associated dementia brains compared with patients without dementia (p < 0.05), but these same cytokines induced PAR-2 expression on neurons. Enhanced PAR-2 expression and subsequent activation prevented neuronal cell death and induction of the tumor suppressor, p53, caused by the HIV-encoded protein, Tat (p < 0.01). Intrastriatal implantation of a PAR-2 peptide agonist also inhibited Tat-induced neurotoxicity in a mouse model of HIV neuropathogenesis (p < 0.05). Moreover, PAR-2 null animals showed more severe neuroinflammation and neuronal loss caused by Tat neurotoxicity (p < 0.05). TNF-alpha protected wild-type neurons from Tat-related neurotoxicity, but in PAR-2-deficient neurons, the same concentrations of TNF-alpha were cytotoxic (p < 0.001). Thus, neuroinflammation can exert protective effects by which it induces PAR-2 expression with the ensuing abrogation of neuronal death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905579     DOI: 10.4049/jimmunol.174.11.7320

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

3.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

4.  West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.

Authors:  Guido van Marle; Joseph Antony; Heather Ostermann; Christopher Dunham; Tracey Hunt; William Halliday; Ferdinand Maingat; Matt D Urbanowski; Tom Hobman; James Peeling; Christopher Power
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

Review 5.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

6.  Protease activated receptor 2 controls myelin development, resiliency and repair.

Authors:  Hyesook Yoon; Maja Radulovic; Grant Walters; Alex R Paulsen; Kristen Drucker; Phillip Starski; Jianmin Wu; David P Fairlie; Isobel A Scarisbrick
Journal:  Glia       Date:  2017-09-18       Impact factor: 7.452

7.  Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration.

Authors:  David Vergote; Georgina S Butler; Martine Ooms; Jennifer H Cox; Claudia Silva; Morley D Hollenberg; Jack H Jhamandas; Christopher M Overall; Christopher Power
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

8.  Tissue factor and heart inflammation.

Authors:  R Pawlinski; N Mackman
Journal:  J Thromb Haemost       Date:  2009-02       Impact factor: 5.824

Review 9.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

10.  CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy.

Authors:  Yu Zhu; David Vergote; Carlos Pardo; Farshid Noorbakhsh; Justin C McArthur; Morley D Hollenberg; Christopher M Overall; Christopher Power
Journal:  FASEB J       Date:  2009-04-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.